Concurrence of Papillary Thyroid Carcinoma and Hürthle Cell Carcinoma in an Iranian Woman with Hashimoto's Thyroiditis

Document Type: Case Reports

Authors

1 Department of Pathology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

2 Medical Student, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

3 General Physician, 553 Army Hospital, Qazvin, Iran

10.30699/ijp.2019.99544.1986

Abstract

The most usual form of the endocrine carcinoma is thyroid cancer (TC). In addition to papillary thyroid carcinoma (PTC), recent studies revealed incidence of RET/PTC rearrangement in other tumors, like Hürthle cell carcinoma (HCC) and even in non-carcinomatous disorders like Hashimoto's thyroiditis. Here, we present a case with concurrence of papillary thyroid carcinoma and Hürthle cell carcinoma.
A 60-year-old woman referred to our hospital with a mass in her neck. Physical examinations revealed painful swelling in the thyroid. Ultrasonographic examination showed two hypoechoic nodules in the right lobe. Hürthle cell variant papillary carcinoma was suggested in the cytology report of the fine needle aspiration. Permanent histopathological diagnosis was co-existence of papillary thyroid carcinoma and Hürthle cell carcinoma. The patient was asymptomatic in 14 months follow up.
Concurrence of papillary carcinoma and Hürthle cell carcinoma is a rare form of thyroid malignancies, with doubtful cytogenetic findings and biological behaviors. The results showed that it is necessary for the surgeons and pathologists to be aware of lesions for the optimal diagnostic and therapeutic interventions. Also, it is vital to follow up patients with the Hashimot’s thyroiditis who have multiple nodules to detect occult thyroid cancers and decide for better therapeutic programs.

Keywords

Main Subjects


  1. Mazeh H, Orlev A, Mizrahi I, Gross DJ, Freund HR. Concurrent mudullary, papillary and follicular thyroid carcinomas and simultaneous Cushing's syndrome. Eur Thyroid J 2015;4(1):65-8. [DOI:10.1159/000368750] [PMID] [PMCID]
  2. Navya NO, Magdalene KF, Satheesh GP. Synchronous Hürthle Cell Carcinoma and Papillary Carcinoma in a Patient with Hashimoto's Thyroiditis: A Rare Case Report. Middle East J Cancer. 2014 Sep 24;5(4):221-4.
  3. Sinno S, Choucair M, Nasrallah M, Wadi L, Jabbour MN, Nassif S. Activating BRAF mutations detected in mixed Hürthle cell carcinoma and multifocal papillary carcinoma of the thyroid gland: report of an unusual case and review of the literature. Int J Surg Pathol. 2016 Sep;24(6):519-24. [DOI:10.1177/1066896916639377] [PMID]
  4. Xie H, Wei B, Shen H, Gao Y, Wang L, Liu H. BRAF mutation in PTC and its association with clinicopathological features and systemic inflammation response index (SIRI). Am J Trans Res. 2018; 10(8): 2726-36.
  5. Liu Z, Zeng W, Huang L, Wang Z, Wang M, Zhou L, et al. Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis. Am J Cancer Res. 2018; 8(8): 1444-1448. [DOI:10.18632/oncotarget.21826]
  6. Ahmadi S, Stang M. Hürthle cell carcinoma: current perspectives. Onco Targets There. 2016; 9: 6873-6884. [DOI:10.2147/OTT.S119980] [PMID] [PMCID]
  7. Gopal RK, Kübler K, Calvo SE, Polak P, Livitz D, Rosebrock D, et al. Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in Hürthle cell carcinoma. Cancer Cell. August 2018; 34(2): 242-255. [DOI:10.1016/j.ccell.2018.06.013] [PMID] [PMCID]
  8. Okani CO, Otene B, Nyaga T, Ngbea J, Eke A, Edegbe F, et al. Report of a case of papillary thyroid carcinoma in association with Hashimoto's thyroiditis. Niger Med J. 2015 Nov;56(6):433-35. [DOI:10.4103/0300-1652.171612] [PMID] [PMCID]
  9. Zaletel K and Gaberscek S. Hashimoto's thyroiditis: from genes to the disease. Current Genomics. Dec 2011; 12(8): 576-588. [DOI:10.2174/138920211798120763] [PMID] [PMCID]
  10. Takano K, Kikuchi K, Matsumiya H, Himi T. Collision tumor of the thyroid: follicular carcinoma plus papillary carcinoma plus adenomatous goiter. Word J of Med Surf case report. 2013 Apr;7: 234-37.
  11. Ko EJ, Lee EK, Lee SW, Choi SI. Rare concurrence of triple primary thyroid cancer: A patient of papillary carcinoma, follicular carcinoma, and primary lymphoma of the thyroid. Int J Thyroidol. 2015 November 8(2):216-220 http://dx.doi.org/10.11106/ijt.2015.8.2.216 [DOI:10.11106/ijt.2015.8.2.216]
  12. Takano K, Kikuchi K, Matsumiya H, Himi T. Collision tumor of the thyroid: follicular carcinoma plus papillary carcinoma plus a demo carcinoma to us goiter. Word J of Med Surf case report. April 2013;7:234-7.
  13. Nikiforov YE. RET/PTC Rearrangement--a link between Hashimoto's thyroiditis and thyroid cancer...or not. J Clinic Endocrinologist Metab. Jun 2006; 91(6): 2040-42. [DOI:10.1210/jc.2006-0791] [PMID]
  14. Patel BK, Roy A, Badhe BA, Siddaraju N. Cytologic aspects of an interesting case of medullary thyroid carcinoma coexisting with Hashimoto's thyroiditis . J cytol. 2016 33(2):100-2 [DOI:10.4103/0970-9371.182534] [PMID] [PMCID]
  15. Vijy Paul T, Rahul George. Collision tumors of the thyroid: review of literature and report of a case of papillary-follicular collision tumor. Thyroid Research & Practice. Jul 2018;15(2):60-64. [DOI:10.4103/trp.trp_6_18]
  16. Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto's thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. Apr 2017;7:53. [DOI:10.3389/fonc.2017.00053] [PMID] [PMCID]
  17. Plauche V, Dewenter T, Walvekar RR. Follicular and papillary carcinoma: a thyroid collision tumor. Indian J Otolaryngol Head Neck Surg. Jul 2013; 65(1):182-4. [DOI:10.1007/s12070-011-0450-0] [PMID] [PMCID]
  18. Ryan N, Walkden G, Lazic D, Tierney O. Collision tumors of the thyroid: A case report and review of the literature. Head Neck. Oct 2015; 37(10):125-9. [DOI:10.1002/hed.23936] [PMID]